Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome is a rare genetic disorder that affects the body’s ability to regulate insulin levels. It is characterized by an abnormally high level of insulin in the blood, which can lead to a variety of symptoms, including low blood sugar, poor growth, and seizures. It is caused by mutations in the genes responsible for the production of insulin, and is usually diagnosed in infancy. Treatment typically involves a combination of dietary changes, medications, and insulin injections.

Symptoms of Atypical Fanconi Syndrome-Neonatal Hyperinsulinism Syndrome can include:

-Low blood sugar (hypoglycemia)
-Poor feeding
-Weakness
-Lethargy
-Irritability
-Seizures
-Developmental delay
-Failure to thrive
-Jaundice
-Enlarged liver
-Enlarged spleen
-Abdominal distention
-Vomiting
-Diarrhea
-Dehydration
-Weight loss
-Muscle wasting
-Hypotonia
-Hypocalcemia
-Hyperammonemia
-Hyperuricemia
-Hyperlipidemia
-Hyperinsulinemia

Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome is caused by mutations in the genes ABCC8 and KCNJ11, which are responsible for the production of proteins involved in the regulation of insulin secretion. Mutations in these genes can lead to an overproduction of insulin, resulting in the symptoms of Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome.

1. Dietary management: Dietary management is the primary treatment for atypical Fanconi syndrome-neonatal hyperinsulinism syndrome. This includes a low-carbohydrate, high-fat diet, with frequent meals and snacks throughout the day.

2. Medication: Medications such as diazoxide, octreotide, and somatostatin analogs may be used to help control blood sugar levels.

3. Surgery: Surgery may be necessary to remove the affected part of the pancreas.

4. Insulin therapy: Insulin therapy may be necessary to help control blood sugar levels.

5. Glucose monitoring: Regular monitoring of blood glucose levels is important to ensure that the treatment plan is working.

1. Family history of Atypical Fanconi Syndrome-Neonatal Hyperinsulinism Syndrome
2. Maternal diabetes
3. Maternal obesity
4. Maternal use of certain medications during pregnancy
5. Advanced maternal age
6. Exposure to certain environmental toxins
7. Genetic mutations in certain genes associated with the syndrome

At this time, there is no cure for Atypical Fanconi Syndrome-Neonatal Hyperinsulinism Syndrome. However, there are medications that can be used to help manage the symptoms of the condition. These medications include insulin, sulfonylureas, and diazoxide. Additionally, dietary modifications and lifestyle changes may be recommended to help manage the symptoms.